Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

Abstract Aims We aimed to assess the impact of pre‐admission beta‐blocker (BB) therapy on the clinical characteristics, in‐hospital treatment and outcomes of patients with cardiogenic shock (CS). Methods All patients enrolled in the multicentre prospective Altshock‐2 registry since March 2020 with a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, Altshock‐2 investigators
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	ESC Heart Failure
Subjects:	Cardiogenic shock beta‐blockers inotropes mortality vasopressors
Online Access:	https://doi.org/10.1002/ehf2.15322
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

Similar Items